Regeneron Pharmaceuticals Inc., of Tarrytown, N.Y., reported that fourth quarter 2015 U.S. net sales of Eylea (aflibercept) injection increased 44 percent to $746 million vs. fourth quarter 2014 and the full year net sales increased 54 percent to $2.68 billion over 2014 net sales.